Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan (Q44289260)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan |
scientific article |
Statements
1 reference
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan (English)
1 reference
Ikuya Miki
1 reference
Nobuo Aoyama
1 reference
Toshiyuki Sakai
1 reference
Daisuke Shirasaka
1 reference
Casmir Marwa Wambura
1 reference
Shuji Maekawa
1 reference
Kohei Kuroda
1 reference
Takao Tamura
1 reference
Tomoko Kita
1 reference
Toshiyuki Sakaeda
1 reference
Katsuhiko Okumura
1 reference
Masato Kasuga
1 reference
1 January 2003
1 reference
1 reference
Identifiers
1 reference